Premium
High‐resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2
Author(s) -
Persson Fredrik,
Andrén Ywonne,
Winnes Marta,
Wedell Barbro,
Nordkvist Anders,
Gudnadottir Gunhildur,
Dahlenfors Rigmor,
Sjögren Helene,
Mark Joachim,
Stenman Göran
Publication year - 2009
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.20619
Subject(s) - hmga2 , biology , gene duplication , carcinoma ex pleomorphic adenoma , fluorescence in situ hybridization , microbiology and biotechnology , fusion gene , gene rearrangement , salivary duct carcinoma , comparative genomic hybridization , cancer research , gene , salivary gland , pleomorphic adenoma , genome , genetics , carcinoma , microrna , chromosome , biochemistry
Carcinoma ex pleomorphic adenoma (Ca‐ex‐PA) is an epithelial malignancy developing within a benign salivary gland pleomorphic adenoma (PA). Here we have used genome‐wide, high‐resolution array‐CGH, and fluorescence in situ hybridization to identify genes amplified in double min chromosomes and homogeneously staining regions in PA and Ca‐ex‐PA and to identify additional genomic imbalances characteristic of these tumor types. Ten of the 16 tumors analyzed showed amplification/gain of a 30‐kb minimal common region, consisting of the 5′‐part of HMGA2 (encoding the three DNA‐binding domains). Coamplification of MDM2 was found in nine tumors. Five tumors had cryptic HMGA2‐WIF1 gene fusions with amplification of the fusion oncogene in four tumors. Expression analysis of eight amplified candidate genes in 12q revealed that tumors with amplification/rearrangement of HMGA2 and MDM2 had significantly higher expression levels when compared with tumors without amplification. Analysis of individual HMGA2 exons showed that the expression of exons 3–5 were substantially reduced when compared with exons 1–2 in 9 of 10 tumors with HMGA2 activation, indicating that gene fusions and rearrangements of HMGA2 are common in tumors with amplification. In addition, recurrent amplifications/gains of 1q11‐q32.1, 2p16.1‐p12, 8q12.1, 8q22‐24.1, and 20, and losses of 1p21.3‐p21.1, 5q23.2‐q31.2, 8p, 10q21.3, and 15q11.2 were identified. Collectively, our results identify HMGA2 and MDM2 as amplification targets in PA and Ca‐ex‐PA and suggest that amplification of 12q genes (in particular MDM2 ), deletions of 5q23.2‐q31.2, gains of 8q12.1 ( PLAG1 ) and 8q22.1‐q24.1 ( MYC ), and amplification of ERBB2 may be of importance for malignant transformation of benign PA. © 2008 Wiley‐Liss, Inc.